203 related articles for article (PubMed ID: 25043619)
1. Angiopoietins promote ovarian cancer progression by establishing a procancer microenvironment.
Brunckhorst MK; Xu Y; Lu R; Yu Q
Am J Pathol; 2014 Aug; 184(8):2285-96. PubMed ID: 25043619
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Tie-2-Expressing Monocytes/Macrophages and Angiopoietins in the Progression of Ovarian Cancer-State-of-the-Art.
Skiba W; Suszczyk D; Pawłowska A; Włodarczyk K; Pańczyszyn A; Wertel I
Cells; 2022 Nov; 11(23):. PubMed ID: 36497114
[TBL] [Abstract][Full Text] [Related]
3. High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer.
Sopo M; Sallinen H; Hämäläinen K; Kivelä A; Ylä-Herttuala S; Kosma VM; Keski-Nisula L; Anttila M
PLoS One; 2020; 15(11):e0241484. PubMed ID: 33151982
[TBL] [Abstract][Full Text] [Related]
4. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.
Yang G; Rosen DG; Liu G; Yang F; Guo X; Xiao X; Xue F; Mercado-Uribe I; Huang J; Lin SH; Mills GB; Liu J
Clin Cancer Res; 2010 Aug; 16(15):3875-86. PubMed ID: 20505188
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.
Ghosh S; Albitar L; LeBaron R; Welch WR; Samimi G; Birrer MJ; Berkowitz RS; Mok SC
Gynecol Oncol; 2010 Oct; 119(1):114-20. PubMed ID: 20619446
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.
Beach JA; Aspuria PJ; Cheon DJ; Lawrenson K; Agadjanian H; Walsh CS; Karlan BY; Orsulic S
Oncotarget; 2016 Jan; 7(4):4167-82. PubMed ID: 26716409
[TBL] [Abstract][Full Text] [Related]
7. Pericytes Promote Malignant Ovarian Cancer Progression in Mice and Predict Poor Prognosis in Serous Ovarian Cancer Patients.
Sinha D; Chong L; George J; Schlüter H; Mönchgesang S; Mills S; Li J; Parish C; Bowtell D; Kaur P;
Clin Cancer Res; 2016 Apr; 22(7):1813-24. PubMed ID: 26589433
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietins in angiogenesis.
Fagiani E; Christofori G
Cancer Lett; 2013 Jan; 328(1):18-26. PubMed ID: 22922303
[TBL] [Abstract][Full Text] [Related]
9. A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer.
Cheon DJ; Tong Y; Sim MS; Dering J; Berel D; Cui X; Lester J; Beach JA; Tighiouart M; Walts AE; Karlan BY; Orsulic S
Clin Cancer Res; 2014 Feb; 20(3):711-23. PubMed ID: 24218511
[TBL] [Abstract][Full Text] [Related]
10. Targeting the ANGPT-TIE2 pathway in malignancy.
Huang H; Bhat A; Woodnutt G; Lappe R
Nat Rev Cancer; 2010 Aug; 10(8):575-85. PubMed ID: 20651738
[TBL] [Abstract][Full Text] [Related]
11. ZNF217 is associated with poor prognosis and enhances proliferation and metastasis in ovarian cancer.
Li J; Song L; Qiu Y; Yin A; Zhong M
Int J Clin Exp Pathol; 2014; 7(6):3038-47. PubMed ID: 25031722
[TBL] [Abstract][Full Text] [Related]
12. Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers.
Ciucci A; Zannoni GF; Buttarelli M; Lisi L; Travaglia D; Martinelli E; Scambia G; Gallo D
Oncotarget; 2016 Feb; 7(7):8155-71. PubMed ID: 26797759
[TBL] [Abstract][Full Text] [Related]
13. Sterol regulatory element-binding protein 1 is required for ovarian tumor growth.
Nie LY; Lu QT; Li WH; Yang N; Dongol S; Zhang X; Jiang J
Oncol Rep; 2013 Sep; 30(3):1346-54. PubMed ID: 23818099
[TBL] [Abstract][Full Text] [Related]
14. Kindlin-2 inhibits serous epithelial ovarian cancer peritoneal dissemination and predicts patient outcomes.
Ren C; Du J; Xi C; Yu Y; Hu A; Zhan J; Guo H; Fang W; Liu C; Zhang H
Biochem Biophys Res Commun; 2014 Mar; 446(1):187-94. PubMed ID: 24583125
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin expression in ovine corpora lutea during the luteal phase: Effects of nutrition, arginine and follicle stimulating hormone.
Gram A; Redmer DA; Kowalewski MP; Dorsam ST; Valkov V; Warang P; Reyaz A; Bass CS; Kaminski SL; Grazul-Bilska AT
Gen Comp Endocrinol; 2018 Dec; 269():131-140. PubMed ID: 30195024
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.
Brunckhorst MK; Wang H; Lu R; Yu Q
Cancer Res; 2010 Sep; 70(18):7283-93. PubMed ID: 20823154
[TBL] [Abstract][Full Text] [Related]
17. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.
Barbolina MV; Adley BP; Shea LD; Stack MS
Cancer; 2008 Apr; 112(7):1632-41. PubMed ID: 18260155
[TBL] [Abstract][Full Text] [Related]
18. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer.
Hu L; Cong L
Oncol Rep; 2015 Nov; 34(5):2683-91. PubMed ID: 26323668
[TBL] [Abstract][Full Text] [Related]
20. [The regulating roles of angiopoietins/TEK-2 in angiogenesis].
Luo Y; Wei YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):63-6. PubMed ID: 16456789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
